跳至主要内容
临床试验/NCT04036669
NCT04036669已完成不适用

Foot Bone Mineral Density and Inflammation in Rheumatoid Arthritis

King Saud University0 个研究点目标入组 160 人开始时间: 2014年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
主要终点
Foot Function Index

研究概览

简要总结

Significant increase in the levels of serum adiponectin, ADA, and hsCRP was reported in all RA patients compared to controls.

Compared to patients with early RA, the increase in these markers significantly correlated with disease activity (DAS-ESR), lower f-BMD, radiographic scoring, pain, FFI, and functional limitations in patients with established RA.

Adiponectin showed a negative correlation with serum levels of both ADA and hsCRP. By using ROC curve analysis, optimal cut-off values of adiponectin (28.8 µg/ml), ADA (27.3 IU/L), and hsCRP (1.6 mg/L) could be used to estimate early RA in 45 % of the patients. Similarly, using cut-off values of adiponectin (32.8 µg/ml), ADA (26.1 IU/L ml), and hsCRP (2.5 mg/L), established RA could be predicted in 55 % of patients with 98-99% accuracy.

详细描述

The present study attempts to evaluate the efficacy of adiponectin, ADA, and foot bone mineral density (fBMD) as predictors of the disease progression in patients with rheumatoid arthritis. A total of 80 RA patients and eighty age and sex-matched healthy controls were included in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients who diagnosed with Rheumatoid arthritis according to American Rheumatology Association criteria and radiographic analysis for at least 10 years previously were randomly involved in this study
  • Not receiving any drugs affecting the data obtained
  • had Normal daily diets

排除标准

  • Subjects with obvious ischemic heart disease (angina, myocardial infarction, and lead electrocardiogram abnormalities),
  • HCV, HBV, chronic liver and kidney diseases, hypothyroidism.
  • Drugs (diuretics; oral contraceptives).

结局指标

主要结局

Foot Function Index

时间窗: 3 months

Foot Function Index (FFI) is pre-validated questionnaire designed efficiently to measure the effects of foot pathologies such as Rheumatoid Arthritis (RA) on foot function in terms of pain, disability and activity restriction. The FFI has three subscales of measurements; pain, disability, and activity limitation with a total of 23 questions and total score of 10. For each patients, record the respective measurements of the FFI three subscales according to the score range (0-10), whereas; patients with no pain (0); mild pain (1-3); moderate pain(4-6), and severe or worse pain (7-10).

Estimation of Foot bone mineral density (f-BMD)

时间窗: 3 months

Foot BMD for all RH patients was performed by Dual Energy X-ray Absorptiometry (DEXA) scan method by using a Lunar DPX densitometer originally used to measure bone mass of small animals and modified to suits the measurements of hand BMD. Foot measurements were applied according to previously reported method

次要结局

  • Assessment of serum Adiponectin concentration(3 months)
  • Assessment of serum Adenosine deaminase (ADA) activity(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sami Gabr

clinical Professor

King Saud University

相似试验